Really good perspective on P and K. Psoriasis is almost impossible to show efficacy in mild inflections. The normal flair ups and remissions overlap to much with what an effective drug wold show. Now moderate to severe psoriasis that’s not the case.
As far as K goes it is probably much more effective in treating patients in the early stages of cancer versus the late stages where all options have been exhausted and the immune system is seriously compromised. Which is what K is having to treat. Almost seems backwards.